文献速递产科母胎医学

超声指征宫颈环扎术对双胎妊娠短宫颈女性极早产预防效果的系统评价与Meta分析

The effectiveness of ultrasound-indicated cerclage for the reduction of extreme preterm birth in twin pregnancies with a short cervix: a systematic review and meta-analysis.
PubMed 文献 · Am J Obstet Gynecol MFM · 2024-11-26

该系统评价与Meta分析纳入3项随机对照试验和13项队列研究(环扎组696例,对照组595例),评估宫颈环扎术对双胎妊娠无症状中孕期短宫颈(≤25 mm)女性早产及新生儿结局的影响。随机对照试验汇总未发现早产发生率显著差异,但环扎组新生儿呼吸窘迫综合征和极低出生体重发生率显著更高;队列研究汇总显示环扎与早产率降低相关,尤其宫颈长度<15 mm者。作者认为环扎可能有益,但需设计良好的随机对照试验进一步验证新生儿结局。

要点

  • 随机对照试验汇总(N=49)未发现环扎与期待治疗在早产发生率上存在显著差异。
  • 队列研究汇总显示环扎与34周、32周、28周早产率降低相关,宫颈<15 mm者获益更明显。
  • 随机对照试验中环扎组新生儿呼吸窘迫综合征和极低出生体重风险显著更高。

核心结论

  • 基于本Meta分析,宫颈环扎术可能使双胎妊娠无症状中孕期短宫颈<25 mm的女性获益,尤其是宫颈<15 mm者,可降低早产并改善新生儿结局。
  • 随机对照试验与近期队列研究之间的差异强调,在临床实践中对这些女性引入环扎术之前,需要针对新生儿结局开展样本量充足的随机对照试验。

研究设计与样本

  • 系统检索MEDLINE、Embase、Web of Science、Scopus和Cochrane Library,截至2023年4月17日,并于2024年9月和2月更新。
  • 纳入比较环扎术与期待治疗的随机对照试验、队列研究和病例对照研究,对象为双胎妊娠无症状短宫颈(≤25 mm)女性。
  • 采用Newcastle-Ottawa质量评估量表和Risk of Bias 2工具评估偏倚风险,使用RevMan 5.4以随机效应模型分析数据。
  • 共分析3项随机对照试验和13项队列研究,涉及环扎组696例和对照组595例。

主要发现

  • 随机对照试验汇总(N=49)在调整早产史和孕周后,未发现早产发生率存在显著差异。
  • 环扎组母亲的新生儿呼吸窘迫综合征发生率显著更高(调整比值比3.88,95%CI 1.09-21.03),极低出生体重发生率也显著更高(调整比值比2.22,95%CI 1.07-5.73)。
  • 队列研究汇总显示,环扎组早产率在34周(相对风险0.75,95%CI 0.63-0.90)、32周(相对风险0.67,95%CI 0.49-0.90)和28周(相对风险0.572,95%CI 0.39-0.83)均显著更低。
  • 环扎还降低了婴儿<1500 g、呼吸窘迫综合征、新生儿重症监护病房入住和脓毒症的风险。
  • 宫颈长度<15 mm且接受环扎的女性,<37周(相对风险0.88,95%CI 0.81-0.94)、34周(相对风险0.70,95%CI 0.57-0.87)、32周(相对风险0.63,95%CI 0.50-0.80)和28周(相对风险0.43,95%CI 0.32-0.59)的早产率更低;环扎组母亲所生新生儿的围产期死亡风险显著更低;宫颈长度16-25 mm的女性中未观察到结局的显著差异。

关键数值与推荐

  • 纳入标准为双胎妊娠且无症状中孕期短宫颈(≤25 mm),比较环扎术与期待治疗。
  • 随机对照试验汇总(N=49)早产发生率无显著差异;环扎组呼吸窘迫综合征调整比值比3.88(95%CI 1.09-21.03),极低出生体重调整比值比2.22(95%CI 1.07-5.73)。
  • 队列研究汇总早产相对风险:34周0.75(95%CI 0.63-0.90),32周0.67(95%CI 0.49-0.90),28周0.572(95%CI 0.39-0.83)。
  • 宫颈长度<15 mm者早产相对风险:<37周0.88(95%CI 0.81-0.94),34周0.70(95%CI 0.57-0.87),32周0.63(95%CI 0.50-0.80),28周0.43(95%CI 0.32-0.59)。
  • 宫颈长度16-25 mm者未观察到结局的显著差异。

临床怎么用

  • 作者认为,宫颈环扎术可能使双胎妊娠无症状中孕期短宫颈<25 mm的女性获益,尤其是宫颈<15 mm者。
  • 作者强调,在临床实践中对这些女性引入环扎术之前,需要针对新生儿结局开展样本量充足的随机对照试验。

局限性

  • 随机对照试验与近期队列研究之间的差异强调需要设计良好的随机对照试验。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aimed to evaluate the effectiveness of cervical cerclage in women with a twin pregnancy and a midpregnancy asymptomatic short cervix (≤25 mm), in preventing preterm birth and improving neonatal outcomes. DATA SOURCES: Systematic searches were conducted in MEDLINE, Embase, Web of Science, Scopus, and Cochrane Library up to April 17, 2023, updated in September and February 2024. STUDY ELIGIBILITY CRITERIA: Included were randomized controlled trials, cohort studies, and case-control studies comparing cerclage with expectant management in twin pregnancies and an asymptomatic short cervix (≤25 mm). METHODS: Risk of bias was assessed using the Newcastle-Ottawa Quality Assessment Scale and the Risk of Bias 2 tool. Data were analyzed using RevMan 5.4 using a random-effects model. RESULTS: Three randomized controlled trials and 13 cohort studies, involving 696 cerclage patients and 595 controls, were analyzed. Combined randomized controlled trial findings (N=49) found no significant difference in preterm birth occurrence after adjustment for preterm birth history and gestational age. Neonates from cerclage-treated mothers exhibited significantly higher rates of respiratory distress syndrome (adjusted odds ratio, 3.88; 95% confidence interval, 1.09-21.03) and very low birthweight (adjusted odds ratio, 2.22; 95% confidence interval, 1.07-5.73). In contrast, pooled cohort data indicated significantly less preterm birth rates in women with a cerclage: at 34 weeks (relative risk, 0.75; 95% confidence interval, 0.63-0.90), 32 weeks (relative risk, 0.67; 95% confidence interval, 0.49-0.90), and 28 weeks (relative risk, 0.572; 95% confidence interval, 0.39-0.83). Cerclage also reduced risk for infants <1500 g, respiratory distress syndrome, admission at the neonatal intensive care unit, and sepsis. Women with cervical length <15 mm and a cerclage experienced fewer preterm birth rates at <37 weeks (relative risk, 0.88; 95% confidence interval, 0.81-0.94), 34 weeks (relative risk, 0.70; 95% confidence interval, 0.57-0.87), 32 weeks (relative risk, 0.63; 95% confidence interval, 0.50-0.80), and 28 weeks (relative risk, 0.43; 95% confidence interval, 0.32-0.59). Perinatal mortality risk was significant lower in neonates born to mothers with a cerclage. For women with cervical length between 16 and 25 mm, no significant differences in outcomes were observed. CONCLUSION: Based on our meta-analysis, cerclage may benefit women with a twin pregnancy with an asymptomatic midpregnancy short cervix <25 mm, especially in women with a cervix <15 mm, by reducing preterm birth and improving neonatal outcomes. However, the differences between randomized controlled trials and recent cohort studies emphasize the need for well-powered randomized controlled trials on neonatal outcomes before introducing cerclage in clinical practice for these women.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. van Gils L, Dutilh R, Denswil N, et al. The effectiveness of ultrasound-indicated cerclage for the reduction of extreme preterm birth in twin pregnancies with a short cervix: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2024. PMID: 39603526. doi:10.1016/j.ajogmf.2024.101555

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。